Skip to content
10-K

Annual Report

Arno Therapeutics, Inc

0001144204-15-020148

← back to feed
Filed
Mar 31, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 25, 2015 20.41M sh
Shares Diluted FY 2014 · Dec 31, 2013 7.52M sh
Capex FY 2014 · Dec 31, 2013 $0
Current Liabilities FY 2014 · Dec 31, 2013 $3.9M
Total Liabilities FY 2014 · Dec 31, 2013 $39.77M
Current Assets FY 2014 · Dec 31, 2013 $26.86M
Total Assets FY 2014 · Dec 31, 2013 $26.88M
Eps Diluted FY 2014 · Dec 31, 2013 −$5.28
Eps Basic FY 2014 · Dec 31, 2013 −$5.28
Sga Expense FY 2014 · Dec 31, 2013 $3.46M
Rd Expense FY 2014 · Dec 31, 2013 $13.48M
Net Income FY 2014 · Dec 31, 2013 −$39.66M
Operating Income FY 2014 · Dec 31, 2013 −$16.94M
Cash And Equivalents FY 2014 · Dec 31, 2012 $10.94M
Stockholders Equity FY 2014 · Dec 31, 2012 −$12.27M